UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018993
Receipt number R000021967
Scientific Title Development of an ex vivo method for evaluation of the mitochondrial function
Date of disclosure of the study information 2015/10/19
Last modified on 2020/10/01 10:12:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of an ex vivo method for evaluation of the mitochondrial function

Acronym

An ex vivo evaluation method for mitochondria

Scientific Title

Development of an ex vivo method for evaluation of the mitochondrial function

Scientific Title:Acronym

An ex vivo evaluation method for mitochondria

Region

Japan


Condition

Condition

MELAS

Classification by specialty

Medicine in general Neurology Pediatrics

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To develop a novel biomarker of MELAS

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Confirming the specificity and sensitivity of the novel biomarker for the disease activities of MELAS, compared to those of the canonical biomarker, serum lactate or the ratio of lactate/pyruvate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Blood sampling to detect the disease-activity of MELAS

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Typical clinical picture of MELAS (myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) with the specific muscle histology (RRF, SSV) and the gene alterations of mitochondrial DNA (A3243G)

Key exclusion criteria

None

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshihide Sunada

Organization

Kawasaki Medical School

Division name

Neurology

Zip code


Address

577 Matsushima, Kurashiki, Okayama, 701-0192

TEL

086-462-1111

Email

ysunada@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshihide Sunada

Organization

Kawasaki Medical School

Division name

Neurology

Zip code


Address

577 Matsushima, Kurashiki, Okayama, 701-0192

TEL

086-462-1111

Homepage URL


Email

ysunada@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development (AMED)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 09 Month 12 Day

Date of IRB

2015 Year 10 Month 29 Day

Anticipated trial start date

2015 Year 10 Month 19 Day

Last follow-up date

2022 Year 10 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 09 Month 12 Day

Last modified on

2020 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021967


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name